End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.7 TWD | -0.39% | +0.40% | -13.04% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Products (including Food)
68.7
%
| - | - | 433 | 68.7 % | - |
Pharmaceuticals
29.8
%
| - | - | 188 | 29.8 % | - |
Others (Note)
0.9
%
| 15 | 2.2 % | 5 | 0.9 % | -64.02% |
Cleaning Products
0.6
%
| - | - | 4 | 0.6 % | - |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 684 | 100.0 % | 629 | 100.0 % | -8.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Hsiu Cheng
CEO | Chief Executive Officer | - | - |
Li Yu Lin
DFI | Director of Finance/CFO | - | 14-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Hsiu Cheng
CEO | Chief Executive Officer | - | - |
Pa Chou Hsieh
BRD | Director/Board Member | - | 14-08-24 |
Yong Sheng Wang
BRD | Director/Board Member | - | 14-08-24 |
Ya I Huang
BRD | Director/Board Member | - | 17-06-07 |
Hui Chien Li
BRD | Director/Board Member | - | 17-11-30 |
Hung Yuan Lin
BRD | Director/Board Member | - | 17-06-07 |
Jui Hsiang Hsu
BRD | Director/Board Member | - | 17-06-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,807,000 | 10,752,500 ( 33.81 %) | 0 | 33.81 % |
Company contact information
Li Kang Biomedical Co. Ltd.
9F, 21, Lane 221, Gangqian Road Neihu District
114, Taipei
+
http://www.bafo.com.twSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.04% | 49.93M | |
+15.92% | 8.35B | |
+3.37% | 7.62B | |
+1.49% | 6.01B | |
-5.33% | 3.75B | |
-7.57% | 3.7B | |
-2.94% | 1.34B | |
-26.08% | 1.13B | |
+14.95% | 992M | |
-9.40% | 925M |
- Stock Market
- Equities
- 6242 Stock
- Company Li Kang Biomedical Co., Ltd.